BIOMAT Database Logo BIOMAT Database Logo

Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma. 1992

C C Huang, and M C Wu, and G W Xu, and D Z Li, and H Cheng, and Z X Tu, and H Q Jiang, and J R Gu
Institute of Hepatobiliary Surgery, Shanghai Hospital, People's Republic of China.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D020168 ATP Binding Cassette Transporter, Subfamily B, Member 1 A 170-kDa transmembrane glycoprotein from the superfamily of ATP-BINDING CASSETTE TRANSPORTERS. It serves as an ATP-dependent efflux pump for a variety of chemicals, including many ANTINEOPLASTIC AGENTS. Overexpression of this glycoprotein is associated with multidrug resistance (see DRUG RESISTANCE, MULTIPLE). ATP-Dependent Translocase ABCB1,MDR1 Protein,MDR1B Protein,Multidrug Resistance Protein 1,P-Glycoprotein,P-Glycoprotein 1,ABCB1 Protein,ATP Binding Cassette Transporter, Sub-Family B, Member 1,ATP-Binding Cassette, Sub-Family B, Member 1,CD243 Antigen,PGY-1 Protein,1, P-Glycoprotein,ABCB1, ATP-Dependent Translocase,ATP Dependent Translocase ABCB1,Antigen, CD243,P Glycoprotein,P Glycoprotein 1,PGY 1 Protein,Protein, MDR1B,Translocase ABCB1, ATP-Dependent

Related Publications

C C Huang, and M C Wu, and G W Xu, and D Z Li, and H Cheng, and Z X Tu, and H Q Jiang, and J R Gu
Overexpression of P-glycoprotein in hepatocellular carcinoma and its clinical implication.
February 2000, World journal of gastroenterology,
C C Huang, and M C Wu, and G W Xu, and D Z Li, and H Cheng, and Z X Tu, and H Q Jiang, and J R Gu
Expression of MDR1/P glycoprotein in human sarcomas.
December 1993, British journal of cancer,
C C Huang, and M C Wu, and G W Xu, and D Z Li, and H Cheng, and Z X Tu, and H Q Jiang, and J R Gu
Expression of the MDR1 gene (P-glycoprotein) in breast cancer.
January 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
C C Huang, and M C Wu, and G W Xu, and D Z Li, and H Cheng, and Z X Tu, and H Q Jiang, and J R Gu
Interaction of structurally diverse pesticides with the human MDR1 gene product P-glycoprotein.
November 1996, Toxicology and applied pharmacology,
C C Huang, and M C Wu, and G W Xu, and D Z Li, and H Cheng, and Z X Tu, and H Q Jiang, and J R Gu
Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms.
March 2010, Biochemical pharmacology,
C C Huang, and M C Wu, and G W Xu, and D Z Li, and H Cheng, and Z X Tu, and H Q Jiang, and J R Gu
MDR1 gene polymorphisms and P-glycoprotein expression in respiratory diseases.
September 2015, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia,
C C Huang, and M C Wu, and G W Xu, and D Z Li, and H Cheng, and Z X Tu, and H Q Jiang, and J R Gu
mdm2 gene mediates the expression of mdr1 gene and P-glycoprotein in a human glioblastoma cell line.
October 1996, British journal of cancer,
C C Huang, and M C Wu, and G W Xu, and D Z Li, and H Cheng, and Z X Tu, and H Q Jiang, and J R Gu
Identification of phosphorylation sites in human MDR1 P-glycoprotein.
January 1998, Methods in enzymology,
C C Huang, and M C Wu, and G W Xu, and D Z Li, and H Cheng, and Z X Tu, and H Q Jiang, and J R Gu
MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine.
May 2002, British journal of clinical pharmacology,
C C Huang, and M C Wu, and G W Xu, and D Z Li, and H Cheng, and Z X Tu, and H Q Jiang, and J R Gu
P-glycoprotein expression in hepatocellular carcinoma.
January 1993, Journal of surgical oncology,
Copied contents to your clipboard!